WHAT'S CHANGING Zepbound vs Saxenda: 2026 Outlook 2026: Saxenda Losing Market Share As newer GLP-1s like Zepbound and Wegovy show superior efficacy, Saxenda (FDA-approved since 2014) is gradually being replaced on formularies
This work was supported in part by the Robert Wood Johnson Foundation (L.H., N.D.P.), the M.J
Whether you are on semaglutide , tirzepatide , or retatrutide , the nutritional challenges are similar
Safety monitoring should include periodic IGF-1 levels and fasting glucose checks, as growth hormone stimulation can affect glucose metabolism
You may be more likely to develop Barretts esophagus if you: A gastroenterologist, a specialist in gastrointestinal diseases, usually diagnoses Barretts esophagus
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States